Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention - Executive Summary | AHRQ Effective Health Care Program

Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention - Executive Summary | AHRQ Effective Health Care Program

New Resources Summarize Evidence on the Use of Adjunctive Devices for Acute Coronary Syndrome

A new set of clinician resources from AHRQ’s Effective Health Care Program summarize the evidence on the comparative effectiveness, benefits and harms of adjunctive devices to prevent or remove blood clots in patients with acute coronary syndrome who are undergoing percutaneous coronary interventions of heart arteries. Current evidence on the use of these devices is too limited to draw firm conclusions about the benefits and harms of one adjunctive device over another. However, catheter aspiration thrombectomy reduced the occurrence of major negative cardiovascular events among patients who suffered a heart attack caused by a blockage in a coronary artery, the evidence showed. The new resources include a clinician summary, CME/CE activity, and faculty slide set, based on the recently released research review, Comparative Effectiveness of Adjunctive Devices to Remove Thrombi or Protect Against Distal Embolization in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention of Native Vessels.

 Adjunctive Devices in PCI To Remove Thrombi or Protect Against Distal Embolization in Patients With ACS - Clinician Summary | AHRQ Effective Health Care Program

Search for Guides, Reviews, and Reports | AHRQ Effective Health Care Program

Slides | AHRQ Effective Health Care Program